Abbvie Inc (NYSE:ABBV) shares, rose in value, with the stock price up by 0.14% to the previous day’s close as strong demand from buyers drove the stock to $203.00.
Actively observing the price movement in the recent trading, the stock is buoying the session at $202.72, falling within a range of $202.505 and $204.19. The value of beta (5-year monthly) is 0.598 whereas the PE ratio is 84.88 over 12-month period. Referring to stock’s 52-week performance, its high was $218.66, and the low was $153.58. On the whole, ABBV has fluctuated by -0.99% over the past month.
With the market capitalization of Abbvie Inc currently standing at about $359.10 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Jan-30. The company’s Forward Dividend Ratio is 6.29, with its dividend yield at 3.10%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABBV’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 5.53, with the price of ABBV currently trading nearly -3.37% and 3.00% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.35, while the 7-day volatility ratio is showing 2.64% which for the 30-day chart, stands at 2.40%. Furthermore, Abbvie Inc (ABBV)’s beta value is 0.56, and its average true range (ATR) is 4.47.
A comparison of Abbvie Inc (ABBV) with its peers suggests the former has fared considerably weaker in the market. ABBV showed an intraday change of 0.14% in today’s session so far, and over the past year, it grew by 13.29%%.
Data on historical trading for Abbvie Inc (NYSE:ABBV) indicates that the trading volumes over the past 10 days have averaged 7.18 and over the past 3 months, they’ve averaged 6.23 million. According to company’s latest data on outstanding shares, there are 1.77 billion shares outstanding.
Nearly 0.11% of Abbvie Inc’s shares belong to company insiders and institutional investors own 73.42% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 19.7 million shares as on 2025-03-14, resulting in a short ratio of 3.1. According to the data, the short interest in Abbvie Inc (ABBV) stood at 111.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 19.62 million. The stock has risen by 14.24% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABBV stock heading into the next quarter.
